Population-level effects of clinical immunity to malaria

BMC Infectious Diseases

Volumn 13, Issue 1, 2013, Pages

  Keegan, Lindsay T ^a   Dushoff, Jonathan ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL IMMUNITY; CONTROLLED STUDY; DISEASE DURATION; IMMUNE RESPONSE; INFECTION RESISTANCE; INFECTION SENSITIVITY; MALARIA; MATHEMATICAL MODEL; PARASITE TRANSMISSION;

HUMANS; MALARIA; MODELS, BIOLOGICAL; POPULATION SURVEILLANCE;

EID: 84883652416     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-13-428     Document Type: Article

References (44)

1. Organization WH. World malaria report. 2012, 1-195.
2. Schofield L, Mueller I. Clinical immunity to malaria. Curr Mol Med 2006, 6(2):205-221. 10.2174/156652406776055221, 16515511.
3. Filipe JAN, Riley EM, Drakeley CJ, Sutherland CJ, Ghani AC. Determination of the processes driving the acquisition of immunity to malaria using a mathematical transmission model. PLoS Comput Biol 2007, 3(12):e255. 10.1371/journal.pcbi.0030255, 2230683, 18166074.
4. Metselaar D, Theil PMV. Classification of malaria. Trop Geogr Malar 1959, 11:157-161.
5. Gatton M, Cheng Q. Modeling the development of acquired clinical immunity to Plasmodium falciparum malaria. Infect Immun 2004, 72(11):6538. 10.1128/IAI.72.11.6538-6545.2004, 523055, 15501785.
6. Gupta S, Snow R, Donnelly C, Marsh K, Newbold C. Immunity to non-cerebral severe malaria is acquired after one or two infections. Nature Med 1999, 5(3):340-343. 10.1038/6560, 10086393.
7. Doolan DL, Dobano C, Baird JK. Acquired immunity to malaria. Clin Microbiol Rev 2009, 22:13-36. 10.1128/CMR.00025-08, 2620631, 19136431.
8. Kurtis J, Mtalib R, Onyango F, Duffy P. Human resistance to Plasmodium falciparum increases during puberty and is predicted by dehydroepiandrosterone sulfate levels. Infect Immun 2001, 69:123. 10.1128/IAI.69.1.123-128.2001, 97863, 11119497.
9. Snow R, Marsh K. Will reducing Plasmodium falciparum transmission alter malaria mortality among African children?. Parasitol Today 1995, 11(5):188-190.
10. OMeara WP, Mwangi TW, Williams TN, McKenzie FE, Snow RW, Marsh K. Relationship between exposure, clinical malaria, and age in an area of changing transmission intensity. Am J Trop Med Hyg 2008, 79(2):185-191. 2547116, 18689622.
11. O'Meara WP, Bejon P, Mwangi TW, Okiro EA, Peshu N, Snow RW, Newton CR, Marsh K. Effect of a fall in malaria transmission on morbidity and mortality in Kilifi, Kenya. The Lancet 2008, 372(9649):1555-1562.
12. Águas R, White LJ, Snow RW, Gomes MGM. Prospects for malaria eradication in sub-Saharan Africa. Plos One 2008, 3(3):1-6.
13. The Global H, the Malaria A. Atlas of malaria eliminating countries. 2011, San Francisco:The Global Health Group, Global Health Sciences, University of California, San Francisco.
14. Chiyaka C, Tatem A, Cohen J, Gething P, Johnston G, Gosling R, Laxminarayan R, Hay S, Smith D. The stability of Malaria elimination. Science 2013, 339(6122):909-910. 10.1126/science.1229509, 23430640.
15. McCombie S. Treatment seeking for malaria: a review of recent research. Soc Sci Med 1996, 43(6):933-945. 10.1016/0277-9536(95)00446-7, 8888463.
16. Owusu-Agyei S, Koram K, Baird J, Utz G, Binka F, Nkrumah F, Fryauff D, Hoffman S. Incidence of symptomatic and asymptomatic Plasmodium falciparum infection following curative therapy in adult residents of northern Ghana. Am J Trop Med Hygiene 2001, 65(3):197-203.
17. Port AL, Cot M, Etard JF, Gaye O, Migot-Nabias F, Garcia A. Relation between Plasmodium falciparum asymptomatic infection and malaria attacks in a cohort of Senegalese children. Malar J 2008, 7:193. 10.1186/1475-2875-7-193, 2567330, 18823542.
18. Bousema J, Gouagna L, Drakeley C, Meutstege A, Okech B, Akim I, Beier J, Githure J, Sauerwein R. Plasmodium falciparum gametocyte carriage in asymptomatic children in western Kenya. Malar J 2004, 3:18. 10.1186/1475-2875-3-18, 441400, 15202944.
19. Earle W, Perez M, del Rio J, Arzola C. Observations on the course of naturally acquired malaria in Puerto Rico. Puerto Rico J Public Heath and Trop Med 1939, 14:391-406.
20. Sama W, Killeen G. SMITH T Estimating the duration of Plasmodium falciparum infection from trials of indoor residual spraying. Am J Trop Med Hygiene 2004, 70(6):625. SMITH T.
21. Bretscher M, Maire N, Chitnis N, Felger I, Owusu-Agyei S, Smith T. The distribution of Plasmodium falciparum infection durations. Epidemics 2011, 3(2):109-118. 10.1016/j.epidem.2011.03.002, 21624782.
22. Szmitko PE, Kohn ML, Simor AE. Plasmodium falciparum malaria occurring 8 years after leaving an endemic area. Diagn Microbiol Infect Dis 2008, 63:105-107.
23. Bruce M, Donnelly C, Packer M, Lagog M, Gibson N, Narara A, Walliker D, Alpers M, Day K. Age-and species-specific duration of infection in asymptomatic malaria infections in Papua New Guinea. Parasitol 2000, 121(03):247-256.
24. Molineaux L, Diebner H, Eichner M, Collins W, Jeffery G, Dietz K. Plasmodium falciparum parasitaemia described by a new mathematical model. Parasitol 2001, 122(04):379-391.
25. Bottius E, Guanzirolli A, Trape JF, Rogier C, Konate L, Druilhe P. Malaria: even more chronic in nature than previously thought; evidence for subpatent parasitaemia detectable by the polymerase chain reaction. Trans R Soc Trop Med Hygiene 1996, 90:15-19.
26. Alves F, Durlacher R, Menezes M, Krieger H, Silva L, Camargo E. High prevalence of asymptomatic Plasmodium vivax and Plasmodium falciparum infections in native Amazonian populations. Am J Trop Med Hygiene 2002, 66(6):641-648.
27. Laishram DD, Sutton PL, Nanda N, Sharma VL, Sobti RC, Carlton JM, Joshi H. The complexities of malaria disease manifestations with a focus on asymptomatic malaria. Malar J 2012, 11:29. 10.1186/1475-2875-11-29, 3342920, 22289302.
28. Schall J. Transmission success of the malaria parasite Plasmodium mexicanum into its vector: role of gametocyte density and sex ratio. Parasitol 2000, 121(06):575-580.
29. Noden B, Beadle P, Vaughan J, Pumpuni C, Kent M, Beier J. Plasmodium falciparum: the population structure of mature gametocyte cultures has little effect on their innate fertility. Acta Tropica 1994, 58:13-19. 10.1016/0001-706X(94)90117-1, 7863850.
30. Drakeley CJ, Bousema JT, Akim NIJ, Teelen K, Roeffen W, Lensen AH, Bolmer M, Sauerwein WERW. Transmission-reducing immunity is inversely related to age in Plasmodium falciparum gametocyte carriers. Parasite Immunol 2006, 28:185-190. 10.1111/j.1365-3024.2005.00818.x, 16629703.
31. Naotunne T, Karunaweera N, Giudice GD, Kularatne M, Grau G, Carter R, Mendis K. Cytokines kill malaria parasites during infection crisis extracellular complementary factors are essential. J Exp Med 1991, 173(3):523-529. 10.1084/jem.173.3.523, 2118826, 1900073.
32. Eckhoff P. P. falciparum infection durations and infectiousness are shaped by antigenic variation and innate and adaptive host immunity in a mathematical model. PLoS ONE 2012, 7(9):e44950. 10.1371/journal.pone.0044950, 3446976, 23028698.
33. Mulder B, Tchuinkam T, Dechering K, Verhave J, Carnevale P, Robert V. JHET M Malaria transmission-blocking activity in experimental infections of Anopheles gambiae from naturally infected Plasmodium falciparum gametocyte carriers. Trans R Soc Trop Med Hygiene 1994, 88(1):121-125. JHET M.
34. Boudin C, Kolk MVD, Tchuinkam T, Gouanga C, Bonnet S, Safeukui I, Mulder B, Meunier JY, Verhave JP. Plasmodium Falciparum transmission blocking immunity under conditions Of low and high endemicity in Cameroon. Parasite Immunol 2004, 26:105-110. 10.1111/j.0141-9838.2004.00689.x, 15225297.
35. Killeen G, Ross A, Smith T. Infectiousness of malaria-endemic human populations to vectors. Am J Trop Med Hygiene 2006, 75(2 suppl):38-45.
36. Ross A, Killeen G, Smith T. Relationships between host infectivity to mosquitoes and asexual parasite density in Plasmodium falciparum. Am J Trop Med Hygiene 2006, 75(2 suppl):32-37.
37. Pethleart A, Prajakwong S, Suwonkerd W, Corthong B, Webber R, Curtis C. Infectious reservoir of Plasmodium infection in Mae Hong Son province, north-west Thailand. Malar J 2004, 3:34. 10.1186/1475-2875-3-34, 526384, 15385050.
38. Migot-Nabias F, Luty A, Ringwald P, Vaillant M, Dubois B, Renaut A, Mayombo R, Minh T, Fievet N, Mbessi J. Immune responses against Plasmodium falciparum asexual blood-stage antigens and disease susceptibility in Gabonese and Cameroonian children. Am J Trop Med Hygiene 1999, 61(3):488-494.
39. Draper C. Observations on the infectiousness of gametocytes in hyperendemic malaria. Trans R Soc Trop Med Hygiene 1953, 47(2):160-165.
40. Killeen G, Ross A, Smith T. Infectiousness of malaria-endemic human populations to vectors. Am J Trop Med hygiene 2006, 75(2 suppl):38-45.
41. Dushoff J. Incorporating immunological ideas in epidemiological models. J Theor Biol 1996, 180:181-187. 10.1006/jtbi.1996.0094, 8759527.
42. R Core Team R: A Language and Environment for Statistical Computing 2012, Vienna, Austria: R Foundation for Statistical Computing, [http://www.R-project.org], R Core Team.
43. Cohen JM, Smith DL, Cotter C, Ward A, Yamey G, Sabot OJ, Moonen B. Malaria resurgence: a systematic review and assessment of its causes. Malar J 2012, 11:1-1. 10.1186/1475-2875-11-1, 3276413, 22212246.
44. von Seidlein L, Greenwood B. Mass administrations of antimalarial drugs. Trends in Parasitol 2003, 19(10):452-460.